Targeted inhibition of WRN helicase by external guide sequence and RNase P RNA
Anna Hitrik1, Ghada Abboud-Jarrous2, Natalie Orlovetskie1
1Department of Microbiology and Molecular Genetics, The Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.
Abstract:
Human WRN, a RecQ helicase encoded by the Werner syndrome gene, is implicated in genome maintenance, including replication, recombination, excision repair and DNA damage response. These genetic processes and expression of WRN are concomitantly upregulated in many types of cancers. Therefore, targeted destruction of this helicase could be useful for elimination of cancer cells. Here, we provide a proof of concept for applying the external guide sequence (EGS) approach in directing an RNase P RNA to efficiently cleave the WRN mRNA in cultured human cell lines, thus abolishing translation and activity of this distinctive 3'-5' DNA helicase-nuclease. Remarkably, EGS-directed knockdown of WRN leads to severe inhibition of cell viability. Hence, further assessment of this targeting system could be beneficial for selective cancer therapies, particularly in the light of the recent improvements introduced into EGSs.
Insights
Targeting Werner syndrome (WRN) helicase with external guide sequences (EGS) effectively silences WRN mRNA, inhibiting cancer cell viability. This approach shows promise for developing novel cancer therapies.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Werner syndrome (WRN) helicase is crucial for genome maintenance.
- WRN expression is elevated in various cancers, making it a potential therapeutic target.
Purpose of the Study:
- To investigate the efficacy of the external guide sequence (EGS) approach for targeted WRN mRNA destruction.
- To evaluate the impact of WRN knockdown on cancer cell viability.
Main Methods:
- Utilized EGS to direct RNase P RNA for specific cleavage of WRN mRNA in human cell lines.
- Assessed the effect of WRN translation inhibition on cell viability.
Main Results:
- EGS successfully directed RNase P RNA to cleave WRN mRNA, abolishing WRN helicase translation and activity.
- Targeted WRN knockdown resulted in significant inhibition of cancer cell viability.
Conclusions:
- The EGS approach provides a proof of concept for targeted WRN mRNA degradation.
- EGS-mediated WRN targeting demonstrates potential for selective cancer therapies.
Related Concept Videos
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
02:15Experimental RNAi
01:20Types of RNA
RNA Performs Diverse...
01:23Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...